NCT04997902 2025-12-23Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)Kura Oncology, Inc.Phase 1/2 Completed45 enrolled
NCT01602315 2020-12-29A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNovartisPhase 1/2 Terminated179 enrolled 38 charts